Valuation: ScandiDos AB

Market Cap 5.59Cr 57.53L 50.58L 47.04L 43.16L 81.08L 56Cr 82.4L 2.18Cr 27Cr 2.16Cr 2.11Cr 95Cr P/E 2024
-5.36x
P/E 2025 221x
Enterprise Value 4.58Cr 47.17L 41.47L 38.57L 35.39L 66.49L 46Cr 67.57L 1.79Cr 22Cr 1.77Cr 1.73Cr 78Cr EV / Sales 2024
1.23x
EV / Sales 2025 0.97x
Free-Float
25.71%
Yield 2024 *
-
Yield 2025 -
1 day+0.58%
1 week+0.58%
Current month+8.12%
1 month+1.17%
3 months-11.73%
6 months-19.91%
Current year-27.31%
1 week 0.86
Extreme 0.86
0.86
1 month 0.79
Extreme 0.79
0.88
Current year 0.79
Extreme 0.79
1.32
1 year 0.79
Extreme 0.79
1.4
3 years 0.79
Extreme 0.79
2.75
5 years 0.79
Extreme 0.79
3.99
10 years 0.79
Extreme 0.79
11.9
Manager TitleAgeSince
Chief Executive Officer 59 06/05/2026
Chief Executive Officer 66 01/03/2001
Director of Finance/CFO 46 01/12/2021
Director TitleAgeSince
Director/Board Member 61 01/10/2018
Director/Board Member 58 01/01/2021
Chairman 56 01/10/2023
Change 5-day change 1-year change 3-year change Capi.($)
+0.58%+0.58%-36.63%-64.69% 50.84L
-0.36%-9.20%+14.18%-38.41% 1.55TCr
-7.90%+5.00%+0.62%+89.29% 164.65Cr
-3.20%-7.65%-41.40%-81.89% 109.45Cr
-1.41%-4.66%-38.14%+11.27% 95Cr
-3.39%-5.61%-34.57%-55.85% 61Cr
-2.46%-5.34%-49.25%-59.41% 50Cr
+1.87%+3.51%+39.11%-52.08% 46Cr
+1.52%-3.98%-57.01%-61.54% 37Cr
-4.04%-6.39%+49.24% - 32Cr
Average -1.88%-2.83%-15.38%-34.81% 214.88Cr
Weighted average by Cap. -1.24%-7.29%+4.96%-30.21%

Financials

2024 2025
Net sales 6.25Cr 64.4L 56.62L 52.66L 48.32L 90.76L 62Cr 92.24L 2.44Cr 30Cr 2.42Cr 2.37Cr 106.33Cr 6.4Cr 65.91L 57.95L 53.89L 49.45L 92.89L 64Cr 94.41L 2.5Cr 31Cr 2.47Cr 2.42Cr 108.83Cr
Net income -1.46Cr -15.08L -13.26L -12.33L -11.31L -21.26L -15Cr -21.6L -57.16L -7.14Cr -56.61L -55.39L -25Cr 3L 33.67T 29.6T 27.53T 25.26T 47.45T 32.51L 48.23T 1L 15.93L 1L 1L 55.59L
Net Debt -15.31L -2L -1L -1L -1L -2L -1.52Cr -2L -6L -74.58L -6L -6L -2.6Cr -1.01Cr -10.36L -9L -8L -8L -14.59L -10Cr -14.83L -39.25L -4.9Cr -38.87L -38.03L -17Cr
Logo ScandiDos AB
ScandiDos AB is a Sweden-based company active within the medical equipment sector. The Company's competence includes the design and development of radiation detectors, electrometers and application software, as well as clinical experience in medical physics and radiation measurements. The Company's business focuses on developing such applications as Arc Therapy - IMAT/VMAT, Tomotherapy, IMRT and Machine QA, among others. ScandiDos AB markets its products under the Delta4 brand. Delta4 offers Delta4AT - At Treatment in-vivo dosimetry for advanced RT and Delta4PT - Pre Treatment volumetric plan QA, among others. It operates in Europe, Asia, North America and Asia, and through numerous distributors and subsidiaries, including Additec GmbH and Conmedica GmbH in Germany, and ScandiDos SAS in France.
Employees
25
Date Price Change Volume
23/26/23 SEK 0.8650 +0.58% 4,065
20/26/20 SEK 0.8600 0.00% 40,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SDOS Stock